| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Oligonucleotide |
| Molecule Category: | UNKNOWN |
| UNII: | EGR9KYM536 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| RNAI INHIBITOR | L-lactate dehydrogenase A chain mRNA RNAi inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hyperoxaluria, Primary | 4 | D006960 | ClinicalTrials |
| Hyperoxaluria, Primary | 4 | D006960 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4594338 |
| FDA SRS | EGR9KYM536 |
CONTENTS